CYTOMX THERAPEUTICS, INC.

Profile

Company Names

CYTOMX THERAPEUTICS, INC.

Addresses

151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA 94080

343 OYSTER POINT BLVD., SUITE 100, SOUTH SAN FRANCISCO, CA 94080

650 GATEWAY BLVD., SUITE 125, SOUTH SAN FRANCISCO, CA 94080

460 WARD DRIVE, STE. E-1, SANTA BARBARA, CA 93111

Phone Numbers

650.515.3185
805-964-9700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$129,624,991.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-06-29 
$30,000,000.00 
$30,000,000.00 
$0.00 
 
4
2015-06-12 
$69,999,999.00 
$69,999,999.00 
$0.00 
Equity 
3
2014-12-22 
$16,499,999.00 
$29,999,999.00 
$13,500,000.00 
Equity 
2
2012-07-26 
$12,599,999.00 
$25,999,999.00 
$13,400,000.00 
Equity 
1
2010-09-22 
$524,994.00 
$524,994.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALAN 
 
ASHWORTH 
DIRECTOR
CAMBRIDGE SCIENCE CORP   |  CYTOMX THERAPEUTICS, INC.
MARCIA 
 
BELVIN 
EXECUTIVE OFFICER
CYTOMX THERAPEUTICS, INC.
WAYNE 
 
CHU 
EXECUTIVE OFFICER
CYTOMX THERAPEUTICS, INC.
NEIL 
 
EXTER 
DIRECTOR
SEVENTH SENSE BIOSYSTEMS, INC.   |  CORIDEA NC1, INC.   |  CYTOMX THERAPEUTICS, INC.   |  ELEMENT SCIENCE, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  GOLDFINCH BIOPHARMA, INC.   |  PLIANT THERAPEUTICS, INC.   |  THIRD ROCK VENTURES V, L.P.   |  REVOLUTION MEDICINES, INC.   |  GOLDFINCH BIO, INC.   |  CEDILLA THERAPEUTICS, INC.   |  DECIBEL THERAPEUTICS, INC.   |  THIRD ROCK VENTURES VI, L.P.
HALLEY 
 
GILBERT 
DIRECTOR
ALLERGY AMULET, INC.   |  ADAGIO THERAPEUTICS, INC.   |  CYTOMX THERAPEUTICS, INC.
FREDERICK 
 
GLUCK 
EXECUTIVE OFFICER, DIRECTOR
CYNVENIO BIOSYSTEMS INC   |  CYTOMX THERAPEUTICS, INC.   |  LUNGLIFE AI, INC.
FREDERICK 
W. 
GLUCK 
EXECUTIVE OFFICER, DIRECTOR
TRUEVISION SYSTEMS INC   |  CYTOMX THERAPEUTICS, INC.
ALAN 
 
HEEGER 
DIRECTOR
CBRITE INC.   |  KONARKA TECHNOLOGIES, INC.   |  CYNVENIO BIOSYSTEMS INC   |  CYTOMX THERAPEUTICS, LLC   |  CYTOMX THERAPEUTICS, INC.   |  CYTOMX THERAPEUTICS HOLDINGS, LLC
CHARLES 
 
HOMCY 
DIRECTOR
PORTOLA PHARMACEUTICALS INC   |  CYTOMX THERAPEUTICS, INC.   |  MYOKARDIA INC   |  PLIANT THERAPEUTICS, INC.   |  FAZE MEDICINES, INC.
HOYOUNG 
 
HUH 
DIRECTOR
CALIBRA MEDICAL, INC.   |  JENNEREX, INC.   |  CYTOMX THERAPEUTICS, INC.   |  ANTRIABIO, INC.   |  RESET THERAPEUTICS, INC.   |  NUVESSE SKIN THERAPIES, INC.   |  JUUL LABS, INC.   |  REZOLUTE, INC.   |  EIDOS THERAPEUTICS, INC.   |  PLIANT THERAPEUTICS, INC.   |  AKARI THERAPEUTICS PLC
RACHEL 
 
HUMPHREY 
DIRECTOR
METHYLGENE INC.   |  CYTOMX THERAPEUTICS, INC.   |  XILIO THERAPEUTICS, INC.   |  NORMUNITY HOLDING COMPANY, LLC
ELAINE 
 
JONES 
DIRECTOR
AQUINOX PHARMACEUTICALS (USA) INC   |  AQUINOX PHARMACEUTICALS INC   |  FLEXION THERAPEUTICS INC   |  MERSANA THERAPEUTICS, INC.   |  MIRNA THERAPEUTICS, INC.   |  BLADE THERAPEUTICS, INC.   |  NEXTCURE, INC.   |  GRITSTONE BIO, INC.   |  CYTOMX THERAPEUTICS, INC.
ELAINE 
V. 
JONES 
DIRECTOR
CYTOMX THERAPEUTICS, INC.   |  NEXTCURE, INC.
JEFF 
 
LANDAU 
EXECUTIVE OFFICER
CYTOMX THERAPEUTICS, INC.
SEAN 
 
MCCARTHY 
EXECUTIVE OFFICER, DIRECTOR
GENSTRUCT INC   |  CYTOMX THERAPEUTICS, INC.   |  ONCORESPONSE INC   |  OCOLO, LLC   |  BACKOPS-AI INC.
JAMES 
 
MEYERS 
DIRECTOR
SUPERCLOUD, INC.   |  ARBUTUS BIOPHARMA CORP   |  CYTOMX THERAPEUTICS, INC.   |  INTRABIO INC.
MANI 
 
MOHINDRU 
DIRECTOR
NOVASENTA INC.   |  CYTOMX THERAPEUTICS, INC.
CHRIS 
 
OGDEN 
EXECUTIVE OFFICER
AUSTIN SPIRITS CO   |  CYTOMX THERAPEUTICS, INC.
FLETCHER 
 
PAYNE 
EXECUTIVE OFFICER
PATHWORK DIAGNOSTICS INC   |  CYTOMX THERAPEUTICS, INC.   |  CATALYST BIOSCIENCES INC
MICHAEL 
E. 
PFAU 
EXECUTIVE OFFICER
CYNVENIO BIOSYSTEMS LLC   |  CYTOMX THERAPEUTICS, LLC   |  VAPORE, INC.   |  CYNVENIO BIOSYSTEMS INC   |  CYTOMX THERAPEUTICS, INC.   |  AGILE RF INC   |  AFFINITY BIOSENSORS LLC
LLOYD 
 
ROWLAND 
EXECUTIVE OFFICER
CYTOMX THERAPEUTICS, INC.
TIM 
 
SHANNON 
DIRECTOR
NOVIRA THERAPEUTICS, INC.   |  ARVINAS, INC.   |  CIVITAS THERAPEUTICS, INC.   |  CYTOMX THERAPEUTICS, INC.   |  VIVACE THERAPEUTICS, INC.   |  SPYRYX BIOSCIENCES, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  NEXTCURE, INC.   |  HALDA THERAPEUTICS, LLC   |  RALLYBIO HOLDINGS, LLC   |  CAPITAL INTEGRATION SYSTEMS LLC   |  AER THERAPEUTICS, INC.
NANCY 
 
STAGLIANO 
EXECUTIVE OFFICER, DIRECTOR
CYTOMX THERAPEUTICS, LLC   |  CYTOMX THERAPEUTICS, INC.   |  BIOASIS TECHNOLOGIES INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  LATIGO BIOTHERAPEUTICS, INC.   |  STAR THERAPEUTICS LLC
GARY 
 
WILCOX 
DIRECTOR
CYTOMX THERAPEUTICS, INC.   |  BIOZONE PHARMACEUTICALS, INC.   |  CYTOMX THERAPEUTICS HOLDINGS, LLC   |  COCRYSTAL PHARMA, INC.   |  ADRX, INC.
MATTHEW 
 
YOUNG 
DIRECTOR
GMB PARTNERS LLC   |  LISTING VILLAGE LLC   |  BAY POINT LABORATORIES, INC.   |  NUTEX HEALTH, INC.   |  CYTOMX THERAPEUTICS, INC.   |  OILEX HOLDING LLC   |  ORSOBIO, INC.   |  HEALING REALTY TRUST, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-08-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-06-29 
2015-06-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-12 
2015-01-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-22 
2012-08-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-26 
2010-09-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2010-09-22 
2010-09-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2010-09-22 
2010-09-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2010-09-22 
2010-09-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2010-09-22 
2010-09-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2010-09-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#